Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesRocket Doctor AI Inc

Rocket Doctor AI Inc

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
0.465 CAD -0.01 ( 1.06%)
Last update at 2026-11-09T19:42:00Z
VOLUME
44369
Market Cap
63.75M

Momentum Score

…

Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.46
Low
0.47
High
52 Week Price Range
0.33
Low
0.98
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Rocket Doctor AI Inc is a publicly listed company with limited publicly available disclosures; its name suggests a focus on AI-enabled healthcare or telemedicine solutions. If the business aligns with that sector, long-term growth drivers could include rising adoption of clinical AI, telehealth expansion, and demand for digital diagnostics, which may benefit revenue scalability and recurring-service models. Investors may find the company attractive for exposure to healthcare AI but should verify business specifics and execution track record.

Principal risks are limited disclosure, unproven operations, regulatory/clinical validation requirements and funding/liquidity uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.47
Dividend Yield
-
Revenue TTM
0.04M
Revenue Per Share
0.00
Gross Profit TTM
0.02M
Debt / Equity
0.19
ROE
-
Net Debt
-1.08M
ROCE
-764.00%
Diluted EPS TTM
-0.16

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -7.55M -3.72M -3.80M -13.86M -2.91M
Net income -7.55M -3.72M -3.80M -13.86M -2.91M
Selling general administrative 5.55M 1.97M 3.20M 11.71M 1.61M
Gross profit 0.01M - -0.38M -0.66M -0.33M
Ebit - -2.49M - - -
Ebitda -7.52M -2.33M - - -
Depreciation and amortization - 0.17M 3.79M 13.90M 2.91M
Operating income -6.06M -2.33M -3.84M -13.92M -2.91M
Other operating expenses 6.07M 2.33M 3.79M 13.90M 2.91M
Interest expense 0.04M 0.08M 0.05M 0.00M -
Net interest income -0.04M -0.08M -0.05M 0.00M -
Total revenue 0.01M 0.00M 0.00M 0.00M -
Total operating expenses 6.07M 2.33M 3.79M 13.90M 2.91M
Cost of revenue - - 0.38M 0.66M 0.33M
Total other income expense net -1.50M -1.40M 0.04M 0.03M -
Net income from continuing ops -7.55M -3.72M -3.80M -13.86M -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 1.28M 0.74M 0.01M 0.94M 0.31M
Other current assets 0.05M 0.01M 0.01M 0.03M -
Total liab 0.49M 1.48M 2.20M 0.83M 0.58M
Total stockholder equity 0.79M -0.74M -2.19M 0.11M -0.26M
Other current liab 0.33M 0.89M 0.19M 0.03M 0.03M
Common stock 25.81M 19.07M 14.51M 14.48M 5.47M
Capital stock 25.81M 19.07M 14.51M 14.48M -
Retained earnings -34.97M -27.53M -23.80M -20.01M -6.14M
Other assets - - - -0.01M -
Cash 1.23M 0.72M 0.00M 0.92M 0.31M
Total current liabilities 0.49M 1.48M 1.84M 0.83M 0.58M
Current deferred revenue - - -1.44M - -
Net debt -1.08M -0.13M 0.56M -0.92M -0.31M
Short term debt 0.15M 0.58M 0.20M - -
Short long term debt 0.15M 0.58M 0.20M - -
Short long term debt total 0.15M 0.58M 0.57M - -
Other stockholder equity - - - -0.01M -
Total current assets 1.28M 0.74M 0.01M 0.94M 0.31M
Net receivables 0.00M 0.02M 0.00M 0.00M -
Long term debt - - 0.37M - -
Inventory - - - - -0.00M
Accounts payable - - 1.44M 0.80M 0.55M
Accumulated other comprehensive income 9.96M 7.72M 7.11M 5.65M 0.41M
Non current assets total 0.00M 0.00M 0.00M 0.01M -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total cash from financing activities 4.97M 1.45M 0.54M 6.94M 1.86M
Net income -7.55M -3.72M -3.80M -13.86M -2.91M
Change in cash 0.52M 0.71M -0.91M 0.60M -0.20M
Begin period cash flow 0.72M 0.00M 0.92M 0.31M 0.52M
End period cash flow 1.23M 0.72M 0.00M 0.92M 0.31M
Total cash from operating activities -4.44M -0.74M -1.46M -6.29M -2.01M
Issuance of capital stock 4.42M 1.35M 0.00M 6.82M -
Change to account receivables 0.02M -0.02M -0.00M -0.00M -0.00M
Other cashflows from financing activities 0.54M - 0.20M 0.12M -
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.06M 0.83M 0.82M 0.23M 0.41M
Stock based compensation 1.53M 0.58M 1.43M 6.99M 0.46M
Other non cash items 1.52M 1.58M 0.09M 0.35M 0.02M
Free cash flow -4.44M -0.74M -1.46M -6.29M -2.01M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AIDR
Rocket Doctor AI Inc		 -0.01
1.06%		 0.47 - - 1671.77 6.46 59.80 -0.39
NARA
Pangenomic Health Inc.		 -
-%		 0.30 - - - 5.38 - -0.11
DMED
Diagnamed Holdings Corp.		 -0.01
14.29%		 0.03 - - - 10.74 - -1.43
AIML
AI/ML Innovations Inc		 -
-%		 0.04 - - 70.85 35.17 68.77 -3.59
UDOC
UniDoc Health Corp.		 0.01
11.11%		 0.05 - - 10.64 668.99 10.94 -9.56

Profile*

Rocket Doctor AI Inc

Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

800 ? 885 West Georgia Street, Vancouver, BC, Canada, V6C 3H1

https://www.treatment.com

Name Title Year Born
Dr. Essam Hamza M.D. CEO & Director 1971
Mr. Richard Atkins Chief Operating Officer NA
Dr. Robert Scott M.D. Chief Innovation Officer NA
Ms. Kelly Pladson Corporate Secretary 1983

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.94
+37.96%
MOON
CAD 5.04
+14.17%
FDY
CAD 4.42
+12.18%
UCU
CAD 2.38
+11.21%
PDN
CAD 8.39
+11.13%
DIV
CAD 3.64
-10.57%
TOI
CAD 99.55
-4.99%
BSX
CAD 0.82
-4.65%
CSU
CAD 3367.07
-4.52%
LMN
CAD 26.82
-4.52%

Equity Sectors*

  • Basic Materials

    +5.01%

  • Communication Services

    -0.62%

  • Consumer Cyclical

    +1.25%

  • Consumer Defensive

    +0.14%

  • Energy

    +1.86%

  • Financial Services

    +1.87%

  • Healthcare

    +1.10%

  • Industrials

    +3.75%

  • Real Estate

    +0.53%

  • Technology

    +2.31%

  • Utilities

    +0.99%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…